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miRNA-mediated gene silencing requires the GW182
proteins, which are characterized by an N-terminal
domain that interacts with Argonaute proteins (AGOs),
and a C-terminal silencing domain (SD). In Drosophila
melanogaster (Dm) GW182 and a human (Hs) orthologue,
TNRC6C, the SD was previously shown to interact with the
cytoplasmic poly(A)-binding protein (PABPC1). Here, we
show that two regions of GW182 proteins interact with
PABPC1: the ﬁrst contains a PABP-interacting motif 2
(PAM2; as shown before for TNRC6C) and the second
contains the M2 and C-terminal sequences in the SD.
The latter mediates indirect binding to the PABPC1
N-terminal domain. In D. melanogaster cells, the second
binding site dominates; however, in HsTNRC6A–C the
PAM2 motif is essential for binding to both Hs and
DmPABPC1. Accordingly, a single amino acid substitution
in the TNRC6A–C PAM2 motif abolishes the interaction
with PABPC1. This mutation also impairs TNRC6s silen-
cing activity. Our ﬁndings reveal that despite species-
speciﬁc differences in the relative strength of the
PABPC1-binding sites, the interaction between GW182
proteins and PABPC1 is critical for miRNA-mediated
silencing in animal cells.
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Introduction
GW182-family proteins are essential in animal cells for
miRNA-mediated silencing (reviewed by Ding and Han,
2007; Eulalio et al, 2009a). Analysis of GW182 domains in
Drosophila melanogaster (Dm) and human cells identiﬁed
two domains that are required for silencing. The ﬁrst is the
N-terminal domain, which contains multiple glycine-trypto-
phan repeats (GW repeats) and confers binding to Argonaute
proteins (AGOs; Behm-Ansmant et al, 2006; Till et al,2 0 0 7 ;
Eulalio et al, 2008; Lazzaretti et al, 2009; Takimoto et al,
2009). The second is a bipartite silencing domain (SD),
consisting of the Mid and C-terminal regions, which elicits
translational repression and degradation of miRNA targets
(Figure 1A; Eulalio et al, 2009b; Lazzaretti et al, 2009;
Zipprich et al, 2009).
Exactly how the bipartite SD of GW182 proteins interferes
with translation and accelerates mRNA degradation is not
completely understood, but recent studies provide important
insight by showing that these domains interact with the
cytoplasmic poly(A)-binding protein PABPC1, both in
D. melanogaster and human cells (Fabian et al, 2009; Zekri
et al, 2009).
PABPC1 is a highly conserved eukaryotic protein that binds
the poly(A) tail of mRNAs and stimulates translation through
multiple interactions with translation factors (reviewed by
Kahvejian et al, 2001; Derry et al, 2006). PABPC1 contains
four N-terminal RNA recognition motifs (RRM1–4), a proline-
rich unstructured linker and a C-terminal domain (termed
PABC or MLLE, because of a conserved KITGMLLE signature
motif in this domain; Figure 1A; Kozlov et al, 2010a). The
MLLE domain recognizes a conserved motif termed PABP-
interacting motif 2 (PAM2), which was ﬁrst identiﬁed in the
translational regulators Paip1 and Paip2 (PABP-interacting
proteins 1 and 2) and is also present in multiple proteins
involved in translation or mRNA decay (Khaleghpour et al,
2001; Roy et al, 2002; Albrecht and Lengauer, 2004; Kozlov
et al, 2004, 2010a).
Interestingly, the SD of TNRC6C contains a PAM2 motif
(previously termed conserved motif III or DUF; Figure 1A).
This PAM2 motif in TNRC6C interacts directly with the
PABPC1 MLLE domain in a way similar of those found in
Paip1 and Paip2 (Fabian et al, 2009; Jı ´nek et al, 2010; Kozlov
et al, 2010b). In particular, when both TNRC6C and Paip2
bind to the MLLE domain, the invariant glutamate, phenyl-
alanine and proline residues of the PAM2 motifs occupy
structurally equivalent positions (Jı ´nek et al, 2010; Kozlov
et al, 2010b). Moreover, when the phenylalanine residue is
substituted with alanine, the interaction of TNRC6C with the
MLLE domain is abolished as shown before for Paip2 (Kozlov
et al, 2004, 2010a,b).
The PAM2 motif is also conserved in DmGW182.
Surprisingly, however, our previous studies showed that
this motif is dispensable for PABPC1 binding in cell lysates
(Zekri et al, 2009). DmGW182 instead binds PABPC1 via
sequences downstream of the PAM2 motif (termed M2), plus
sequences in the very C-terminal (C-term) region (Figure 1A).
Nevertheless, the afﬁnity of these regions for PABPC1 in-
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4146creases when the PAM2 motif is included (Zekri et al, 2009);
however, deleting the PAM2 motif does not affect the
DmGW182 silencing activity in vivo (Eulalio et al, 2009b).
The M2 and C-term regions of DmGW182 do not interact with
the MLLE domain of DmPABPC1 but rather interact with the
N-terminal PABPC1 RRM domains (Zekri et al, 2009). These
observations raise a key question: Do the differences in
human TNRC6C and DmGW182 reﬂect differences in the
mechanisms of silencing between these distant species?
Another important question that remains open is to what
extent the interaction between GW182 proteins and PABPC1
contributes to silencing in vivo. Currently, two lines of evi-
dence support a role for PABPC1 in silencing. First, over-
expressing PABPC1 in both D. melanogaster and human cells
suppresses silencing (Zekri et al, 2009; Walters et al, 2010).
Second, depleting PABPC1 from cell-free extracts abolishes
miRNA-mediated deadenylation (Fabian et al, 2009). It has
been difﬁcult to obtain more direct evidence of a role for
PABPC1 in the miRNA pathway (i.e. using RNAi knockdowns)
because depleting PABPC1 causes rapid cell death and general
mRNA destabilization (Behm-Ansmant et al, 2007).
In this study, we investigate further the interaction of
DmGW182 and human TNRC6A–C proteins with PABPC1.
We show that PABPC1 provides two binding sites for GW182
proteins: one on the MLLE domain and another on the RRM
domains. Conversely, GW182 proteins contain two PABPC1-
binding sites: the PAM2 motif, which confers direct binding to
the MLLE domain (as shown before for TNRC6C; Fabian et al,
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Figure 1 PABPC1 provides two binding sites for GW182 proteins. (A) Domain organization of HsPABPC1, HsTNRC6B isoform 1 and
DmGW182. PABPC consists of four N-terminal RRM domains, a proline-rich unstructured linker, and a conserved C-terminal domain, termed
MLLE. HsTNRC6B and DmGW182 consist of an N-terminal AGO-binding domain, which contains multiple GW-repeats (yellow); and a bipartite
silencing domain (SD) which includes the Mid (M) and C-terminal regions but not the RRM. UBA, ubiquitin-associated domain;
Q-rich, region rich in glutamine; PAM2, PABP-interacting motif 2; RRM, RNA recognition motif; M1 and M2, regions within the Mid (M)
domain; C-term, C-terminal region. (B) S2 cells were transfected with a plasmid expressing V5-tagged DmPABPC1 together with plasmids for
expression of GFP-tagged proteins (DmGW182, human TNRC6A–C, or ﬁreﬂy luciferase (F-Luc, which served as a negative control)). Three
days after transfection, cells were lysed and proteins were immunoprecipitated using a polyclonal anti-GFP antibody. Inputs and
immunoprecipitates were analysed by western blotting using anti-GFP and anti-V5 antibodies. The presence of endogenous AGO1 in the
immunoprecipitates was analysed using a speciﬁc anti-AGO1 antibody. (C–E) The interaction of GFP-TNRC6B or GFP-GW182 with full-length
DmPABPC1-V5 or the indicated PABPC1 deletion mutants (V5 tagged) was analysed as described in panel (B). Note that in panel (E), cell
lysates were treated with micrococcal nuclease prior to immunoprecipitation.
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deﬁned sequence comprising the M2 and C-term regions,
which interacts indirectly with the PABPC1 RRMs (as shown
before for DmGW182; Zekri et al, 2009). Both sites contribute
to PABPC1-binding in vivo, but for the human proteins, the
dominant interaction is between PABPC1 MLLE and PAM2,
whereas for DmGW182, the critical interaction is with
PABPC1 RRMs. These results reconcile the apparent discre-
pancy between earlier studies in human and D. melanogaster
cells (Fabian et al, 2009; Zekri et al, 2009).
We also show that in D. melanogaster cells depleted of
endogenous GW182, human TNRC6B can rescue silencing.
Remarkably, this ability to restore silencing is abrogated by a
single amino acid substitution in the PAM2 motif of TNRC6B.
This mutation also abolishes TNRC6s binding to both Dm and
HsPABPC1. Moreover, a chimeric DmGW182 construct con-
taining the PAM2 motif, plus the M2 and C-term regions of
human TNRC6B, requires the PAM2 motif to interact with
PABPC1. Importantly, a phenylalanine to alanine substitution
within the PAM2 motif abrogated both PABPC1 binding and
the silencing activity of the chimeric protein. Finally, we
show that a TNRC6A protein lacking the PAM2 motif or
carrying a single amino acid substitution in this motif does
not interact with HsPABPC1 and is strongly impaired in
restoring silencing in human cells depleted of endogenous
TNRC6A and TNRC6B. Together, our results deﬁnitively
establish a crucial role for GW182–PABPC1 interaction in
the miRNA pathway.
Results
PABPC1 provides two binding sites for GW182 proteins
Previous studies reported that DmGW182 and TNRC6C
interact with different PABPC1 domains (see Introduction).
Therefore, we wished to determine whether, the species-
speciﬁc binding differences reside in the GW182 proteins,
in PABPC1 or both. To do this, we examined the interaction of
human TNRC6s with DmPABPC1 in D. melanogaster
Schneider-2 cells (S2 cells). In S2 cells, the expression level
of TNRC6B was comparable to that of DmGW182, whereas
human TNRC6A and TNRC6C were expressed at lower levels
(Figure 1B, lanes 2–5). Nevertheless, considering the amount
of proteins detected in the immunoprecipitates, the three
human proteins coimmunoprecipitated DmPABPC1 and
endogenous DmAGO1 more efﬁciently than DmGW182
(Figure 1B, lanes 7–10).
To deﬁne the domains in DmPABPC1 that are important for
the interaction with either DmGW182 or human TNRC6B, we
tested each with a series of DmPABPC1 deletion mutants.
PABPC1 contains four RRMs connected to the C-terminal
MLLE domain by a ﬂexible linker (Figure 1A; Derry et al,
2006). Deleting RRM1 reduced the PABPC1 interaction with
both DmGW182 and TNRC6B (Figure 1C and D, lane 18
versus lane 16). In contrast, deleting the MLLE domain
inhibited PABPC1 from binding to TNRC6B but not to
DmGW182 (Figure 1C and D, lane 28). Deleting RRM2,
RRM3, RRM4 or the linker region had no effect in any of
these interactions (Figure 1C and D, lanes 19–26). Together,
these results indicate that PABPC1 has two binding sites for
GW182 proteins: one that is contributed by the RRM1 domain
and another by the MLLE domain.
We next asked whether PABPC1 RRMs or the MLLE
domain were sufﬁcient for binding to DmGW182 and
TNRC6B, respectively. We observed that TNRC6B interacted
with PABPC1 fragments comprising either the RRMs or the
MLLE domain (Figure 1E, lanes 15 and 18). However, these
interactions were less efﬁcient than those observed with full-
length PABPC1 (Figure 1E, lane 12), suggesting that the RRM
and the MLLE domains contribute (additively or synergisti-
cally) to the interaction with TNRC6B. Furthermore, we
conﬁrmed that, in cell lysates, DmGW182 interacts with the
PABPC1 RRMs but not the MLLE domain as shown before
(Figure 1E, lanes 14 and 17; Zekri et al, 2009). Importantly,
the interactions shown in Figure 1E were observed in cell
lysates treated with micrococcal nuclease, suggesting that
they are not mediated by RNA.
GW182 proteins interact with PABPC1 through two
distinct binding sites
We next tested how the various sequences within the SDs of
DmGW182 and TNRC6B contribute to PABPC1 binding. Both
SDs consist of four segments: M1, PAM2 motif, M2 and
C-term (Figures 1A and 2A). Deleting the TNRC6B PAM2
motif abolished the interaction with PABPC1, whereas no
effect was observed when the M2 and C-term regions were
deleted individually (Figure 2B, lanes 10–12). When, how-
ever, the M2 and C-term regions were both deleted, then
PABPC1 binding was reduced, suggesting that these regions
work in concert to bind PABPC1 (Figure 2B, lane 13). Thus,
for TNRC6B, although the PAM2 motif is the high-afﬁnity
PABPC1-binding site, the M2 and C-term regions also
contribute.
In the case of DmGW182, we previously reported that the
same three regions (PAM2 motif and the M2 and C-term
regions) contribute to PABPC1 binding (Zekri et al, 2009).
However, the contribution of the PAM2 motif and the M2
region was apparent only when binding to PABPC1 was
impaired, for example by deleting the C-term region (Zekri
et al, 2009). The results shown in Figure 2C conﬁrm and
extend these previous observations. Indeed, we conﬁrmed
that the interaction of GW182 with PABPC1 is not affected
when the M2 region or the PAM2 motif are deleted individu-
ally (Figure 2C, lanes 13 and 14; Zekri et al, 2009). In
contrast, deleting the C-term region reduced PABPC1 binding
(Figure 2C, lane 15). PABPC1 binding was further decreased
when the C-term region was deleted in combination with the
M2 region or the PAM2 motif (Figure 2C, lanes 16 and 17;
Zekri et al, 2009). PABPC1 binding was abolished when all
three regions were deleted (i.e. PAM2, M2 and C-term;
Figure 2C, lane 19; Zekri et al, 2009). Similar results were
obtained when cell lysates were treated with micrococcal
nuclease (Supplementary Figure S1).
An important implication of the results shown in Figure 2C
is that the GW182 C-term region provides a major PABPC1-
binding sites in cell lysates, however, the M2 region and the
PAM2 motif also contribute, although on their own they are
not sufﬁcient. This conclusion is further supported by experi-
ments aimed at deﬁning the minimal PABPC1-binding do-
main in DmGW182. We observed that a protein fragment
containing the PAM2 motif and the M2 and C-ter regions was
sufﬁcient for PABPC1 binding (Supplementary Figure S2A,
lane 17 versus lane 13; Zekri et al, 2009), whereas fragments
containing one or two of these sequences exhibited reduced
GW182–PABPC1 interaction is required for silencing
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Figure S2A, lanes 15, 16 and 18–22). These results remained
unchanged in the presence of micrococcal nuclease
(Supplementary Figure S2B).
The results described above, together with the observation
that DmGW182 interacts with the RRM domains as efﬁciently
with full-length PABPC1, suggest that the role of the M2
and C-term regions is to confer binding to PABPC1 RRMs.
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Figure 2 GW182 proteins contain two PABPC1-binding sites. (A) Sequence alignment of PAM2 motifs of human TNRC6A–C, Paip2 and
DmGW182. Invariant residues are shown in red. The asterisk indicates the phenylalanine residue that is substituted with alanine in our
mutants (Mut). Dots indicate the residues in the PAM2 motif of GW182 that were substituted in the experiment shown in Figure 3B. (B, C)S 2
cells expressing GFP-TNRC6B, GFP-DmGW182 or the corresponding protein mutants together with DmPABPC1-V5 were lysed 3 days after
transfection. Proteins were immunoprecipitated from cell lysates using a polyclonal anti-GFP antibody and analysed by western blotting as
described in Figure 1. (D) Interaction of GFP-DmGW182 or the indicated mutants with a V5-tagged DmPABPC1 fragment containing RRM1–4.
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the RRM1–4 domains and tested how well it interacts with
various GW182 deletion mutants. We observed that deleting
the M2 and C-term regions inhibited DmGW182 from inter-
acting with the PABPC1 RRMs as efﬁciently as deleting the
entire SD (which includes the PAM2 motif); in contrast,
deleting the PAM2 motif alone had no effect (Figure 2D,
lanes 8–10). Collectively, these results clearly demonstrate
that the M2 and C-term regions interact with DmPABPC1
RRM domains in cell lysates.
A single amino acid substitution in the PAM2 motif
of human TNRC6s abolishes binding to DmPABPC1
The PAM2 motifs from diverse proteins contain three invar-
iant residues EF(X)P that occupy equivalent structural posi-
tions when bound to an MLLE domain (Figure 2A; Jı ´nek et al,
2010; Kozlov et al, 2010a,b). In particular, the invariant
phenylalanine residue is critical for this interaction: if this
phenylalanine is substituted with alanine then the Paip2 and
TNRC6C PAM2 motifs cannot bind PABPC1 (Kozlov et al,
2004, 2010a,b). Similarly, this substitution abolishes the
TNRC6B interaction with DmPABPC1 as efﬁciently as deleting
the entire PAM2 motif (Figure 2B, lane 14; Figure 3A, lane
16). The critical role of the invariant phenylalanine residue in
the interaction with DmPABPC1 was conﬁrmed for TNRC6A
and TNRC6C SDs (Figure 3A, lanes 14 and 18). The equiva-
lent substitution in the PAM2 motif of DmGW182 had only a
minor effect on DmPABPC1 binding, as expected (Figure 3A,
lane 12).
The coimmunoprecipitation assays suggest that the
D. melanogaster PAM2 motif has a relatively lower afﬁnity
for the DmPABPC1 MLLE domain. This might be because the
motif lies in a suboptimal sequence context. However, we
consider this possibility unlikely because the human PAM2
motif is functional in the context of DmGW182 (i.e. it
enhances DmGW182 binding to PABPC1; see below
Figure 8A). An alternative explanation is that the afﬁnity
may be lower because a negatively charged residue sits at the
core of the PAM2 motif (between the invariant phenylalanine
and proline residues, Figure 2A). Indeed, negatively charged
residues are extremely rare at the equivalent position in
PAM2 motifs from diverse proteins and are absent in all
PAM2 motifs validated experimentally (Albrecht and
Lengauer, 2004; Kozlov et al, 2010a). Additionally, in the
human TNRC6A–C, the invariant residues of the PAM2 motifs
are preceded by proline residues that establish hydrophobic
interactions with the MLLE domain (Kozlov et al, 2010b),
these residues are substituted with valine and glutamine in
DmGW182 (Figure 2A).
We therefore tested whether substituting residues in the
PAM2 motif of GW182 with the residues present in the
human proteins could enhance PABPC1 binding.
Substituting the GW182 PAM2-motif amino acids V958 and
Q959 with prolines enhanced GW182 binding to DmPABPC1
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Figure 3 The invariant phenylalanine residue in human PAM2 motifs is essential for binding to DmPABPC1. (A) The interaction of
DmPABPC1-V5 with GFP-tagged DmGW182 or human TNRC6A–C silencing domains was analysed by coimmunoprecipitation assays as
described in Figure 1B. Protein mutants (Mut) contain an alanine to phenylalanine substitution in the PAM2 motif (see Figure 2A, asterisk).
(B) S2 cells transiently expressing DmPABPC1-V5 together with GFP-GW182 wild type or the indicated GW182 mutants were lysed 3 days after
transfection. Proteins were immunoprecipitated from cell lysates using anti-GFP antibodies and analysed as described in Figure 1B. GW182
mutants carry substitutions of the amino acids that are indicated with dots in Figure 2A.
GW182–PABPC1 interaction is required for silencing
E Huntzinger et al
The EMBO Journal VOL 29 | NO 24 | 2010 &2010 European Molecular Biology Organization 4150(Figure 3B, lane 8 versus lane 7). Similar results were
obtained when the negatively charged residue E962 was
substituted with glutamine as in TNRC6B (Figure 3B, lane
9). The two GW182 mutants interacted with DmPABPC1 as
efﬁciently as TNRC6B (Figure 3B, lane 10). Thus, the differ-
ences in the amino acid sequences of these PAM2 motifs can
account for the different afﬁnities for the DmPABPC1 MLLE
domain.
The PAM2 motifs of human TNRC6s are essential
for binding to HsPABPC1
We next analysed whether the human proteins interact in a
similar way with HsPABPC1. We transfected human HEK-293
cells with plasmids expressing either wild-type TNRC6A–C
SDs or the corresponding mutants carrying the phenylalanine
to alanine substitution in the PAM2 motifs. We observed that
the single amino acid substitution in the PAM2 motifs was
sufﬁcient to abolish the interaction with endogenous PABPC1
(Figure 4A–C). Thus, the PAM2 motifs of TNRC6A–C are
essential in mediating binding to both Hs and DmPABPC1.
We also tested whether the M2 and C-term regions of
human TNRC6s contribute to PABPC1 binding in human
cell lysates. Remarkably, deleting either the M2 or C-terminal
regions in the TNRC6C SD reduced the interaction with
PABPC1, whereas deleting the RRM from TNRC6C had no
effect (Figure 4D, lanes 12–14). As a control, we conﬁrmed
that deleting the PAM2 motif (or the entire Mid domain)
abrogated PABPC1 binding (Figure 4D, lanes 10 and 11).
Similar results were obtained when cell lysates were treated
with micrococcal nuclease (data not shown). These ﬁndings
demonstrate that TNRC6s contain two PABPC1-binding sites:
the PAM2 motif and the M2 plus C-term regions.
To investigate whether the interaction mediated by the
M2 and C-term regions of GW182 proteins is direct, we
performed glutathione S-transferase (GST) pull-down assays
with recombinant proteins expressed in Escherichia coli.
These experiments revealed the following observations:
First, we observed that a GST-tagged C-terminal fragment
of TNRC6B containing the PAM2 motif and the downstream
protein sequences (i.e. M2, RRM and C-term) interacted with
both human and DmPABPC1, but did not interact with the
corresponding PABPC1 mutants lacking the MLLE domain
(Figure 4E, lanes 11 versus 14, and 27 versus 30, respec-
tively). Second, deleting the PAM2 motif abolished the inter-
action of TNRC6B SD with both Hs and DmPABPC1
(Figure 4E, lanes 12 and 28, respectively; Figure 5A, lane
10), in agreement with the coimmunoprecipitation assays. In
contrast, deleting the M2 and C-terminal regions did not
affect PABPC1-binding in vitro (Figure 5A, lane 13).
Surprisingly, in vitro, the interaction of DmGW182 SD with
DmPABPC1 was mediated by the PAM2 motif (Figure 5B, lane
10 versus lane 9). Accordingly, a GW182 SD mutant lacking
the M2 and C-terminal regions pulled down DmPABPC1
(Figure 5B, lane 13). Together, these results indicate that
the PAM2 motifs of GW182 proteins mediate direct binding
to PABPC1, whereas the M2 and C-term regions interact with
PABPC1 indirectly, most likely through additional proteins
present in cell lysates. Alternatively, the interaction of the
M2 and C-term regions with PABPC1 may require post-
translational modiﬁcations that do not occur in bacteria.
Importantly, the observation that the DmGW182 PAM2
motif directly interacts with DmPABPC1 in vitro, but is
neither sufﬁcient nor necessary for binding to DmPABPC1
in cell lysates, suggest that the DmPAM2 motif might not be
able to efﬁciently compete with additional PAM2-containing
proteins for binding to PABPC1 in D. melanogaster cells.
GW182 silencing activity correlates with PABPC1
binding
To evaluate how the interaction between GW182 and PABPC1
contributes to silencing, we tested whether DmGW182 mu-
tants that are impaired in PABPC1 binding in cell lysates
could complement silencing in cells lacking endogenous
GW182. To this end, we used a complementation assay
described before (Eulalio et al, 2009b). In this assay, endo-
genous GW182 is depleted using a dsRNA that targets the
coding sequence of the GW182 mRNA. This depletion inhi-
bits miRNA-mediated silencing (Figure 6A–G). GW182 mu-
tants were then tested for the ability to restore silencing in
GW182-depleted cells. Transcripts encoding the recombinant
proteins were made resistant to the dsRNA by introducing
mutations that disrupt basepair interactions with the dsRNA
without altering the protein sequence.
We monitored miRNA activity using two different repor-
ters: the F-Luc-Par-6 reporter which is degraded in the pre-
sence of miR-1 and the F-Luc-Nerﬁn reporter which is
silenced by miR-9b or miR-279 mainly at the translational
level (Behm-Ansmant et al, 2006; Eulalio et al, 2007). We
observed that, independently of the reporter, a DmGW182
mutant lacking the PAM2 motif fully rescued silencing
(Figure 6A–F). Deleting the M2 region had a slight inhibitory
effect (particularly for the F-Luc-Par-6 reporter), whereas
deleting the C-term region impaired silencing for all reporters
as shown before (Figure 6A–F; Eulalio et al, 2009b). When in
addition to the C-term region, the PAM2 motif and the M2
region were deleted, the silencing activity of the protein
decreased further and was comparable to that of the protein
lacking the entire SD (Figure 6A–F). Note that these deletion
mutants did not rescue silencing even though they were
expressed at higher levels than the wild type (Figure 6H).
Moreover, the activity of wild-type GW182 and mutants
remained unchanged when the amounts of transfect plasmid
were increased up to 10-fold (Supplementary Figure S3). We
conclude that the silencing activity of GW182 mutants
strongly correlates with the ability to bind to PABPC1.
Nevertheless, because several regions of DmGW182 must
be deleted to abolish PABPC1-binding in vivo, we cannot
rule out that these regions are also required for additional
functions.
Human TNRC6s complement silencing in
D. melanogaster cells
Next, we investigated whether the human proteins could
restore silencing in S2 cells depleted of endogenous
DmGW182. As shown above, depleting endogenous GW182
suppresses silencing of the F-Luc-Par-6 reporter, leading to a
ﬁve- to nine-fold increase in ﬁreﬂy luciferase expression
(Figure 6A and B; Supplementary Figure S4). Expressing a
dsRNA-resistant form of GW182 fully restored silencing, over
a broad range of transfected expression plasmid (from 10 to
200ng; Supplementary Figures S3 and S4). Similarly, expres-
sing TNRC6B restored silencing almost as efﬁciently as
GW182 (Supplementary Figure S4). In contrast, TNRC6A
and TNRC6C rescued silencing signiﬁcantly only when the
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silencing domains of TNRC6A–C or the indicated mutants were lysed 2 days after transfection. Proteins were immunoprecipitated from
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(Supplementary Figure S4). The differences in silencing
activity between TNRC6s could be due to differences in
protein expression levels (see Figure 1B) and not to incom-
patibility with the D. melanogaster silencing machinery, as all
three human proteins interact with DmAGO1 and PABPC1
(Figure 1B). However, it is possible that TNRC6A and
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Figure 6 DmGW182 silencing activity correlates with the ability to bind
PABPC1 in cell lysates. (A–F) S2 cells were treated with dsRNA targeting
t h ec o d i n gs e q u e n c eo fGW182 mRNA. Control cells were treated with
GST dsRNA. These cells were subsequently transfected with a mixture
of three plasmids: one expressing the indicated F–Luc miRNA reporters;
another expressing miRNA primary transcripts or the corresponding
empty vector ( ); and a third expressing Renilla luciferase (R–Luc).
Plasmids (10ng) encoding wild-type GFP-GW182 or various deletion
mutants were included in the transfection mixtures, as indicated. Fireﬂy
luciferase activities were normalized to those of the Renilla luciferase
transfection control and set to 100 in cells transfected with the empty
vector (i.e. in the absence of miRNAs). (A, C, E) Normalized ﬁreﬂy
luciferase activities in the absence or presence of miRNAs in control
cells (i.e. cells treated with GST dsRNA and expressing GFP). (B, D, F)
The relative fold derepression for each condition. Mean values±s.d.
from three independent experiments are shown. (G) The effectiveness
of the GW182 depletion was analysed by western blotting using anti-
GW182 antibodies. In lanes 1–4, dilutions of untreated cells (control)
are loaded. Blots were probed with anti-tubulin antibodies to test for
equal loading. (H) Expression levels of full-length GW182 and mutants.
F-Luc-GFP served as a transfection control.
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required for silencing.
The TNRC6s–PABPC1 interaction is required
for silencing
As TNRC6B can complement silencing in S2 cells and a single
point mutation in TNRC6B is sufﬁcient to prevent binding to
PABPC1 both in vivo and in vitro, we had the opportunity to
test whether the TNRC6B–PABPC1 interaction is relevant for
silencing in a cellular context. In complementation assays in
S2 cells, we observed that a TNRC6B mutant lacking the
PAM2 motif was strongly impaired (Figure 7A–F). More
importantly, a protein carrying the phenylalanine to alanine
substitution in the PAM2 motif (Mut, F1370A) also failed to
rescue silencing (Figure 7A–F). The equivalent mutation in
GW182 (Mut, F961A) had no effect (Figure 7A–F). Deleting
the TNRC6B M2 and C-term regions also affected silencing
(Figure 7A–F); however, whether this effect reﬂects that these
regions indirectly contribute to PABPC1 binding or that they
have additional functions in silencing is unknown.
For the F-Luc-Par-6 reporter that is directed to degradation
by miR-1, we analysed transcript levels by Northern blotting.
In control cells expressing miR-1, F-Luc-Par-6 mRNA levels
were strongly reduced (Figure 7G, lane 2 versus lane 1).
Depleting GW182 inhibited miR-1-mediated mRNA degrada-
tion as reported before (Figure 7G, lane 4; Eulalio et al, 2008).
Transfecting GW182-depleted cells with a plasmid expressing
either wild-type GW182 or TNRC6B, restored mRNA degra-
dation (Figure 7G, lanes 6 and 12). The GW182 mutant
lacking the PAM2 motif also mediated mRNA degradation
(Figure 7G, lane 8). In contrast, the TNRC6B mutant lacking
the PAM2 motif could not trigger reporter degradation
(Figure 7G, lane 14). The control, a GW182 lacking the M2
and C-term regions, failed to restore mRNA degradation
(Figure 7G, lane 10). The mutant proteins were expressed
at comparable or slightly higher levels than wild type
(Figure 7H). We conclude that the TNRC6B–PABPC1 interac-
tion is required for silencing of miRNA targets, regardless of
whether the target is degraded (F-Luc-Par-6) or translation-
ally repressed (F-Luc-Nerﬁn).
A chimeric GW182 protein requires the interaction with
PABPC1 to elicit silencing
To further investigate how the GW182–PABPC1 interaction is
relevant in silencing, we sought to engineer a DmGW182
protein that requires the PAM2 motif to bind to PABPC1.
Initially, we generated a DmGW182 variant in which the
PAM2 motif was substituted with the TNRC6B PAM2 motif
(GW182-PAM2
6B). This chimeric protein interacted with Dm
PABPC1 more efﬁciently than wild-type GW182 (Figure 8A,
lane 13 versus lane 11); however, if the F1370A substitution
in the PAM2 motif was introduced, binding to PABPC1 was
comparable to that of wild-type GW182 (Figure 8A, lane 14
versus lane 11). Accordingly, in cells depleted of endogenous
GW182, the chimeric protein complemented silencing regard-
less of the F1370A substitution (Figures 8B–G). These results
further support the conclusion that in the context of
DmGW182, the PAM2 motif is dispensable for both PABPC1
binding and silencing.
Next, in addition to the PAM2 motif, we substituted the
M2, RRM and C-term sequences of DmGW182 with those
from TNRC6B (GW182-SD
6B). This chimeric protein behaved
like TNRC6B with respect to PABPC1 binding (Figure 8A).
Indeed, relative to wild-type GW182, the PABPC1-binding
efﬁciency increased (Figure 8A, lane 15 versus lane 11).
More importantly, the F1370A substitution strongly reduced
the interaction with PABPC1 (Figure 8A, lane 16 versus lane
15). Thus, as for TNRC6B, the chimeric protein relies mainly
on the PAM2 motif to interact with PABPC1. In complementa-
tion assays, the chimeric protein carrying the F1370A sub-
stitution was impaired (Figure 8B–G), indicating that the
interaction of GW182 proteins with PABPC1 is critical for
silencing of miRNA targets.
The interaction of TNRC6A with PABPC1 is critical
for silencing in human cells
So far, we demonstrated that the interaction between TNRC6s
and PABPC1 has a critical function in silencing in D. mela-
nogaster S2 cells. To determine whether this is also true in
human cells, we examined whether overexpressing TNRC6C
in HeLa cells stimulated silencing of an R-Luc reporter con-
taining three let-7-binding sites in the 30 UTR (Pillai et al,
2005). We found that TNRC6C enhanced silencing, decreas-
ing luciferase activity an additional two-fold relative to con-
trol cells (Figure 9A and B). In contrast, the TNRC6C mutant
carrying the F1389A substitution failed to stimulate silencing
(Figure 9A and B).
Next, we depleted TNRC6 proteins using speciﬁc siRNAs
and tested whether siRNA-resistant forms of the TNRC6s
could complement silencing in depleted cells. We observed
that siRNAs targeting TNRC6A and TNRC6B efﬁciently sup-
pressed silencing of the let-7 reporter in HeLa cells (Figure 9C
and D; other combinations of siRNAs and protein expression
were less effective, data not shown). In cells codepleted of
TNRC6A and TNRC6B, the expression of wild-type TNRC6A
partially restored silencing, while the TNRC6A mutant
either lacking the PAM2 motif or carrying the F1359A sub-
stitution were impaired in restoring silencing, although they
were expressed at comparable levels as the wild type (Figure
9C–E). A TNRC6A mutant lacking the entire SD was inactive
in the complementation assay, although this mutant was
expressed at higher levels (Figure 9C–E). Altogether, these
data support the idea that the interaction of TNRC6s
with PABPC1 is also critical for silencing miRNA targets in
human cells.
Discussion
Proteins of the GW182 family have an essential function in
the miRNA pathway in diverse organisms (reviewed by Ding
and Han, 2007; Eulalio et al, 2009a). The GW182 N-terminal
and C-terminal domains interact with AGOs and PABPC1,
respectively (reviewed by Tritschler et al, 2010). Here, we
show that the GW182–PABPC1 interaction plays a crucial role
in miRNA-mediated gene silencing.
GW182 proteins are PABP-interacting proteins (Paips)
We found GW182 proteins are similar to Paip1 and Paip2 in
that they contain two binding sites for PABPC1: one in the
PAM2 motif and another in the M2 and C-terminal regions
(Figure 9F). In human TNRC6A–C and DmGW182, the PAM2
motif interacts directly with the C-terminal MLLE domain of
PABPC1. Previous structural and functional studies indicated
that the PAM2 motifs in TNRC6C, Paip1 and Paip2 are
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Figure 7 miRNA-mediated gene silencing requires TNRC6B interaction with PABPC1. (A–F) Complementation assays were performed with
wild-type TNRC6B and various TNRC6B mutants (10ng) and the indicated miRNA reporters, as described in Figure 6. Wild-type GW182 and
the corresponding F961A mutant served as controls. (G) Northern blot analysis of representative RNA samples are shown in panels (A, B).
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Kozlov et al, 2010b). Our ﬁndings extend this conclusion to
the PAM2 motifs of TNRC6A and TNRC6B. Indeed, substitut-
ing alanine for the invariant phenyalanine in the PAM2 motif
abolished binding to Hs or DmPABPC1 for all three human
TNRC6 proteins (Figures 2B, 3A and 4). Nevertheless, the M2
and C-term regions also contribute to PABPC1 binding in cell
lysates (Figures 2B and 4D). In DmGW182, the M2 and
C-terminal site mediates binding to the RRM domains at the
PABPC1 N-terminus (Figure 2D); this binding is most likely
mediated by additional proteins and not by RNA because
it is also observed in cell lysates treated with micrococcal
nuclease.
For human TNRC6A–C, PABPC1 binding is mediated pre-
dominantly by the PAM2 motifs (Figure 9F). In D. melano-
gaster cell lysates, in contrast, the GW182 PAM2 motif is
dispensable for PABPC1 binding. Nevertheless, the D. mela-
nogaster PAM2 motif contributes to PABPC1 binding, because
when it is deleted from a protein lacking the C-term region,
PABPC1-binding efﬁciency decreases further (Figure 2C).
Thus, although the human and D. melanogaster PAM2 motifs
and M2 and C-term regions differ in their contribution to
PABPC1-binding in vivo (Figure 9F), it is likely that TNRC6s
and GW182 form complexes with PABPC1 that are function-
ally equivalent. Accordingly, human TNRC6CA–C can com-
plement silencing in S2 cells depleted of endogenous
DmGW182 (Figure 7; Supplementary Figure S4), indicating
that silencing mechanisms are conserved between these
organisms.
How does the GW182–PABPC1 interaction contribute
to silencing?
Although both Paip1 and Paip2 contain PAM2 motifs, and
interact with PABPC1 in a similar manner, they affect transla-
tion in opposite ways: Paip1 stimulates translation whereas
Paip2 inhibits translation (Kahvejian et al, 2001; Khaleghpour
et al, 2001; Derry et al, 2006). Clearly, GW182 proteins are
likely to act like Paip2 and interfere with PABPC1 function in
translation and/or mRNA stabilization. So, how do GW182
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Figure 9 The interaction of TNRC6s with PABPC1 contributes to
silencing in human cells. (A, B) Human HeLa cells were transfected
with a mixture of three plasmids: the R-Luc-3xlet-7 or the corre-
sponding reporter lacking let-7-binding sites (R-Luc-Mut), a plasmid
expressing ﬁreﬂy luciferase as a transfection control, and plasmids
expressing GFP or the indicated GFP-tagged proteins. Renilla luci-
ferase activity was normalized to that of the ﬁreﬂy luciferase and set
to 100 in cells expressing the reporter lacking the let-7-binding sites
for each condition. (A) Normalized Renilla luciferase activities
in control cells (i.e. cells expressing GFP). (B) Relative silencing
activity for each condition. Mean values±s.d. are shown. (C–E)
HeLa cells were transfected with a control b-Gal siRNA or a mixture
of siRNAs targeting TNRC6A and TNRC6B. Two days later, cells
were re-transfected with the same siRNAs and a mixture of three
plasmids: the R-Luc-3xlet-7 or the corresponding reporter lacking
let-7-binding sites (R-Luc-Mut), a plasmid expressing F-Luc as a
transfection control, and plasmids expressing MBP or siRNA-resis-
tant versions of HA-TNRC6A wild type or mutants. Cells were
harvested 48h after the second transfection. Renilla luciferase
activity was measured and normalized to that of the F-Luc and
set to 100 in cells expressing the reporter lacking the let-7-binding
sites for each condition. (C) Normalized Renilla luciferase activities
in control cells (i.e. cells treated with b-Gal siRNA and expressing
MBP). (D) The relative fold derepression for each condition.
Mean values±s.d. are shown. (E) Protein expression levels.
(F) Schematic diagram showing the interaction of HsTNRC6B and
DmGW182 silencing domains with the N- and C-terminal domains
of PABPC1. Protein domains are as described in Figure 1A. Red lines
indicate the dominant interactions observed in cell lysates. Dashed
lines indicate interactions observed only in cell lysates but not with
recombinant proteins expressed in E. coli.
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that GW182 proteins prevent mRNA circularization as de-
scribed previously with Paip2 (Karim et al, 2006). This idea is
based on the observation that the SD of DmGW182 competes
with eukaryotic initiation factor 4G (eIF4G) for binding to
PABPC1 in cell lysates (Zekri et al, 2009). eIF4G interacts with
the N-terminal RRMs of PABPC1; this interaction stimulates
translation by enabling the mRNA to adopt a closed-loop
conformation (reviewed by Kahvejian et al, 2001).
Consequently, by interfering with PABPC1–eIF4G interaction,
GW182 proteins could inhibit translation. Moreover, when an
mRNA is in the open conformation, the 50 cap and poly(A)
tail could be more accessible to the mRNA decay enzymes
leading to mRNA degradation.
Another mechanism by which the PABPC1–GW182 inter-
action could contribute to silencing is by reducing PABPC1
afﬁnity for the poly(A) tail as described for Paip2
(Khaleghpour et al, 2001). This could render the poly(A)
tail more accessible to deadenylases and thus indirectly
interfere with mRNA circularization.
Finally, it is notable that not all proteins containing a PAM2
motif act directly on PABPC1, as shown for Paip1 and Paip2.
Other proteins such as human TOB for example, just use
PABPC1 as a binding platform that allows them to hook onto
mRNAs using a PAM2 motif. TOB also interacts with the
CAF1–CCR4–NOT mRNA deadenylase complex, and thus
through its interaction with PABPC1, it can promote dead-
enylation of mRNAs (Ezzeddine et al, 2007). Analogously, it
is possible that a GW182–PABPC1 complex might provide a
binding platform for additional interactions required in silen-
cing; these could include interactions with the CAF1–CCR4–
NOT1 deadenylase complex. Indeed, Fabian et al (2009)
showed that PABPC1 is required for the accelerated dead-
enylation of miRNA targets observed in vitro. Here we show
that the role of GW182–PABPC1 interaction is not restricted
to promoting deadenylation but rather this interaction is
required for silencing independently of whether or not the
target is degraded. Thus GW182–PABPC1 interaction may
contribute to silencing through multiple mechanisms.
Independently of the precise molecular mechanism, our
ﬁndings indicate that PABPC1 has a crucial function in
miRNA-mediated gene silencing in animal cells.
Materials and methods
DNA constructs
Luciferase reporters and plasmids for expression of miRNAs and
epitope-tagged proteins were described before (Zekri et al, 2009;
Eulalio et al, 2007, 2008, 2009b). cDNAs encoding human TNRC6A
and C were cloned into the HindIII and XhoI site of plasmid pAc5.1-
EGFP. Human TNRC6B cDNA was cloned into the HindIII and XbaI
sites of plasmid pAc5.1-EGFP. Mutations in DmGW182, DmPABPC1
and human TNRC6A–C were generated by site-directed mutagen-
esis using the Quick Change mutagenesis kit from Stratagene. The
protein GW182-PAM2
6B consist of DmGW182 protein sequences in
which the PAM2 motif (residues T952–Q971) were replaced with
the PAM2 motif of human TNRC6B (residues S1361–Q1380), the
corresponding PAM2-motif sequences are shown in Figure 2A). In
GW182-SD
6B protein sequences downstream of DmGW182 residue
N937 were replaced with TNRC6B sequences downstream of
residue S1361, which contain the PAM2 motif, the M2 and C-term
regions and the RRM.
Complementation and luciferase assays in S2 cells
Complementation assays were performed as described before
(Eulalio et al, 2008, 2009b). Transfections of S2 cells were
performed in 24-well plates, using Effectene transfection reagent
(Qiagen). For miRNA-mediated silencing assays, the transfection
mixtures contained 0.02mg of ﬁreﬂy luciferase reporter plasmid,
0.08mg of the Renilla transfection control and 0.04mg of plasmids
expressing miRNA primary transcripts or the corresponding vector
without insert. When indicated, 10–200ng of plasmids expressing
recombinant proteins were cotransfected. Fireﬂy and Renilla
luciferase activities were measured 3 days after transfection using
the Dual-Luciferase Reporter Assay System (Promega). Total RNA
was isolated using TriFast (Peqlab Biotechnologies) and analysed as
described before (Eulalio et al, 2007).
Coimmunoprecipitations and western blots in S2 cells
For coimmunoprecipitation assays, S2 cells (10–12 10
6 cells) were
collected 3 days after transfection, washed with PBS and lysed in
0.5ml of NET buffer (50mM Tris at pH 7.4, 150mM NaCl, 1mM
EDTA, 0.1% Triton) supplemented with protease inhibitors.
Immunoprecipitations were performed as described by Zekri et al
(2009). When indicated, cell lysates were supplemented with
2.5mM CaCl2, treated with micrococcal nuclease (NEB, M0247S)
for 30min and spun at 18000g for 15min at 41C prior to
immunoprecipitation. Antibodies to AGO1 (dilution 1:1000) were
purchased from Abcam (catalogue number ab5070). Endogenous
GW182 and GFP-tagged proteins were detected with polyclonal
antibodies raised in rabbits. V5-tagged proteins were detected with
anti-V5 antibodies (Invitrogen, dilution 1:5000). All western blot
experiments were developed with the ECL Western blotting
detection system (GE Healthcare) as recommended by the
manufacturer.
Coimmunoprecipitations and western blots in human cells
Plasmids driving the expression of full-length TNRC6A–C or the
corresponding SDs in human cells were described by Lazzaretti et al
(2009). For coimmunoprecipitation assays, HEK-293 cells were
grown in 10cm dishes and transfected using the calcium phosphate
method. The transfection mixtures contained 25mg of plasmid for
expression of HA-tagged TNRC6A–C SDs. Two days after transfec-
tion, cells were washed with PBS and lysed for 15min on ice in NET
buffer supplemented with protease inhibitors and 10% glycerol
(1ml NET buffer/plate). Cell lysates were treated with RNase A for
30min and spun at 18000g for 15min at 41C. Alternatively, cell
lysates were supplemented with 2.5mM CaCl2 and treated with
micrococcal nuclease for 30min. Monoclonal anti-HA antibodies
(Covance) were added to the supernatants (dilution 1:200).
Samples were incubated for 1h at 41C. Then, 25ml of GammaBind
G Sepharose (GE Healthcare) were added and the mixtures were
rotated for an additional hour at 41C. Beads were washed three
times with NET buffer. Bound proteins were eluted with 100mlo f
protein sample buffer and analysed by western blotting. Endogen-
ous PABP was detected with a polyclonal anti-PABPC1 antibody
(Abcam ab21060; dilution 1:3000).
Luciferase assays in human cells
Renilla and ﬁreﬂy luciferase reporters were described before (Pillai
et al, 2005; Lazzaretti et al, 2009). For overexpression assays,
human HeLa cells were seeded in six-well plates and transfected
using the calcium phosphate method. The transfection mixtures
contained 0.05mg of R-Luc-3xlet-7 reporter plasmid or the corre-
sponding reporter carrying mutations in the let-7-binding sites (R-
Luc-Mut), 0.5mg of the pEGFP-N3-F-Luc transfection control and
3mg of plasmids expressing GFP or GFP-protein fusions. R-Luc and
F-Luc activities were measured 48h after transfection using the
Dual-Luciferase Reporter Assay System (Promega).
For complementation assays, human HeLa cells (0.25 10
6) were
seeded in six-well plates in DMEM media without antibiotics (day
0). On day 1, cells were transfected with a mixture of two siRNAs
targeting TNRC6A and TNRC6B, respectively (75pmol of each)
using Lipofectamine 2000 transfection reagent. Alternatively, cells
were transfected with a control siRNA targeting b-Gal. On day 2,
cells are reseeded in 12-well plates at 0.25 10
6 cells per well in
DMEM without antibiotics. On day 3, cells are retransfected with
the same mixture of siRNAs and three plasmids: one expressing
the R-Luc-3xlet-7 reporter (20ng) or the corresponding reporter
carrying mutations in the let-7-binding sites (R-Luc-Mut), one
expressing the transfection control (120ng, pEGFP-N3-F-Luc); and a
third plasmid (165ng) expressing HA-tagged TNRC6A wild type or
mutants or MBP. Cells were harvested 48h after the second
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UCUCCGUGCUCAATT-30; TNRC6B 50-GGCCUUGUAUUGCCAGCAA
TT-30; b-Gal 50-CUACACAAAUCAGCGAUUUUU-30; Dharmacon).
GST pull-down assays
To express the SDs of TNRC6B (amino acids 1361–1723) or
DmGW182 (amino acids 937–1384) in E. coli, the corresponding
cDNAs were cloned into the pGEX6P1 vector (GE healthcare),
resulting in N-terminal GST fusions. Deletions and mutations were
introduced using the QuikChange mutagenesis kit (Stratagene) and
the appropriate oligos. For the MBP-tagged HsPABPC1 or
DmPABPC1 constructs, the corresponding cDNAs were cloned into
the pETM41 vector, resulting in N-terminal fusions with MBP.
For the GST pull-down assays shown in Figure 4E, 12g of
puriﬁed GST, GST-TNRC6B SD or the corresponding DPAM2 mutant
were added to lysates from E. coli cells expressing MBP-tagged
HsPABPC1, MBP-DmPABPC1 or the corresponding mutants lacking
the MLLE domain in a total volume of 1ml of binding buffer (10mM
Hepes (pH 7.5), 150mM NaCl, 2mM MgCl2, 1mM EDTA and 1%
[v/v] Triton-X100). Samples were incubated with 40ml GST beads
(50% slurry) for 1h at 41C. The beads were washed three times
with 1ml of binding buffer. The proteins were eluted with 40mlo f
sample buffer (50mM Tris–HCl (pH 6.8), 2% SDS, 10% (v/v)
gylcerol, 100mM DTTand 0.05% bromophenol blue) and analysed
on a 10% SDS–PAGE.
For the GST pull-down assays shown in Figure 5, lysates from
E. coli cells expressing GST, GST-TNRC6B-SD, GST-DmGW182-SD or
the indicated deletion mutants, were incubated with 40ml GST
beads (50% slurry) in lysis buffer (10mM Hepes (pH 7.5), 300mM
NaCl, 5mM MgCl2 and 1mM DTT) for 1h at 41C. The beads were
washed three times with 1ml of lysis buffer. The pre-coated beads
were then incubated with B25mg of recombinant MBP-HsPABPC1
or MBP-DmPABPC1 in a total volume of 1ml of binding buffer (see
above) for 1h at 41C. The beads were washed three times with 1ml
of binding buffer. Proteins were eluted with 40ml of sample buffer
and separated on a 10% SDS–PAGE.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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